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Advent of drug combinations in Highly Active Antiretroviral Therapy (HAART) has been a major 
achievement in the management of HIV/AIDS. However, some of the drugs involved e.g. protease inhibitors 
have as side effects metabolic disorders like diabetes mellitus DM and dyslipidemia due to affectation of 
the pancreas and 
other organs. 
 
A cross-sectional study to determine the knowledge of health care workers on DM, HIV and how some of 
the drugs used in treating HIV infection secondarily cause metabolic disease like DM. Self-administered, 
pre-tested questionnaires were distributed to 279 health workers from the primary and secondary health 
care facilities in Osun state attending state wide workshops on GDM organized by Strategy for Improving 
Diabetes Care in Nigeria (SIDCAIN) team. 
 
Two thirds (66.2%) of the respondents had good knowledge on DM, while about three quarters (76.3%) 
had good knowledge on HIV. Only about a third (32.4%) of all respondents had good knowledge on effects 
of drugs management of HIV on DM. Health care providers have poor knowledge of HAART induced DM. 
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About 70% of people living with HIV/AIDS 
(PLWHA) worldwide are in Sub-Sahara Africa 
where nearly 30 million individuals with this 
condition live (WHO 2011). Similarlly, the 
burden of DM in Sub-Sahara Africa is expected to 
reach 
23.9 Million by 2030 (IDF 2009). Both diseases 
are responsible for the death of millions of 
people in Sub-Sahara Africa annually (Mbanya et 
al. 2010). Therefore, it is imperative to focus 
attention on proper management of these 
chronic diseases as well as effective measures so 
as to stem the tide of the epidemics. In order to 
achieve these objectives, knowledge of the health 
care professionals in the sub-region must be up 
to date at all times as knowledge is power 
(Adeleke et al. 2014).  Advent of drug 
combinations in highly active anti- retroviral 
therapy (HAART) has broken a  major ground in 
the western countries and elsewhere in the 
struggle to reduce the morbidity and mortality 
that result from human immunodeficiency virus 
(HIV) infection and AIDS ( EL et al. 2001). This 
has also helped the patients to cope better 
(improved quality of life) with the challenges 
posed by this chronic condition. However, 
administration of these drugs  for  a  prolonged 
period of  time has created another group 
challenges (such as drug side effects and 
complications) for the patients and their health 
care providers ( Bakari et al. 2007). 
 
Complications such as bone marrow 
suppression, dyslipidaemia, peripheral 
lipodystrophy, insulin resistance and 
occasionally frank DM have been reported in a 
number of patients on HAART (Kino et al. 2003 
and Carr A et al. 1998). All anti- retroviral drugs 
have adverse effects, but they are indicated in 
HIV positive individuals irrespective of CD4 and 
T lymphocyte counts (Heath et al 2003). 
Emphasis is now on individualized careful drug 
selections to minimize both short and long term 
complications. Among factors influencing anti- 
retroviral drug action or toxicity are  
 
 
concomitant use of other medications with 
additive toxicity, co- morbidity and  genetics 
(Saves    et  al.  2000 and Mallal  et al. 2008). The 
silent implication is that a 
good level of knowledge of health care providers 
is imperative in other not to swell further the 
population of people living with diabetes 
mellitus in Sub-Sahara Africa as a consequence of 
inappropriate use of HAART. 
 
One of the objectives of antiretroviral therapy is 
to reduce the rate of viral replications while 
giving the patient’s immune system some time to 
readjust and respond to the disease. The group of 
drugs used in HAART include the Nucleosides, 
Non- nucleosides and the Protease Inhibitors. 
The protease inhibitors have been particularly 
implicated in the development of 
hyperlipidaemia, insulin resistance and DM (Carr   
et al. 1998, Justman et al. 2003 and Brown   et al. 
2005). Detailed pathogenesis may not be fully 
understood, but it involved specific organ 
mitochondria injuries, and damage to the 
pancreas and the liver (Heath   et al. 2003). Also 
in a Swiss HIV cohort study, HAART regimens 
containing protease inhibitors were found to 
predispose to the development of type 2 
Diabetes Mellitus (Bruno et al. 2007) 
 
In  2007 a  case  of  Diabetes Mellitus induced by 
HAART in 48 years old male Nigerian who has 
been on anti-retroviral drugs for five years 
including six months  of  HAART  was  reported  
(Bakari,  et  al. 
2007). The patient responded to Insulin therapy 
and modification of HAART. Nigeria has more 
than half a million people on anti-retroviral 
therapy (ART), Physicians managing these 
patients need to be aware of such complications 
in order to carefully select the drug combinations 
to prevent DM and to make early diagnosis 
whenever a patient developed such 
complication. 
 
The main objective of the study was to assess 
the knowledge of diabetes mellitus(DM) and  
     Sierra Leone Journal of Biomedical Research 
        A publication of the College of Medicine and Allied Health Sciences, University of Sierra Leone 
© Sierra Leone Journal of Biomedical Research                                        SSN 2076-6270 (Print) 
 Vol 8(2), pp.44-53, December, 2016                                                               ISSN 2219-3170 (Online First) 
 
 
Sierra Leone J Biomed Res Dec. 2016 Vol. 8 No. 2              http://www.sljbr.org/index.php                          46                                                                                                                                                                                  
http://dx.doi.org/10.4314/sljbr.v8i2.6                                 
 
Human immunodeficiency virus (HIV) -
coinfection and the aetiological role of HAART 
among health care workers in primary and 
secondary health facilities in Osun state, south 
west Nigeria. 
A publication of the College of Medicine and 
Allied Health Sciences, University of Sierra 
Leone) 
We assessed the basic knowledge of DM and HIV 
among different categories of health care 
Providers. To determine their knowledge of 
HAART induced DM among HIV positive patients 
 
MATERIALS AND METHODS 
 
This was a cross-sectional study that intended to 
determine the knowledge of health care workers 
on DM, HIV and how some of the drugs used in 
treating HIV infection can cause DM. 
 
The study employed the use of self-administered 
pre-tested questionnaires which were 
distributed to health workers from the primary 
and secondary health care facilities in Osun state 
attending state wide workshops on GDM 
organised by Strategy for Improving Diabetes 
Care in Nigeria (SIDCAIN) team. 
 
Participants were drawn from the 9 General 
Hospitals, 44 Comprehensive Health Centres and 
the Primary Health Centres in the state. Three 
training sessions were held in each of the 3 
senatorial districts  in  the  state spread across  9 
major towns. 
 
The categories of health care workers included 
Medical doctors – Health care professionals that 
possess at least the basic qualification of MBBS or 
the equivalent registered by the Medical and 
Dental Council of Nigeria; Nurses/Midwives – 
Health care professionals with certificates 
registered by the Nursing Council of Nigeria. Also 
included were Pharmacists, Medical laboratory 
scientists and Community health extension 




Section A of the questionnaire contained the 
demographic data of the respondents. Sections B 
and C addressed basic knowledge on DM and HIV 
respectively while Section D was on how drug 
therapy of HIV causes DM. The questionnaires 
were distributed and filled on the last days of the 
trainings. 
 
Ethical approval was sought and obtained from 
the College of Health Sciences, Health Research 
and Ethics Committee of the Osun State 
University. Confidentiality of information and 
respondents identities were assured and 




Generated data were analysed using the SPSS 
version 17.0 software. Frequency and 
percentage tables were drawn where 
appropriate. Outcome measures were tested for 
significance with a p- value less than 0.05 
considered significant 
Each correct knowledge question was assigned a 
score of 1 while incorrect answers were awarded 
0, thus a maximum score of 15 was obtainable for 
Section B (Knowledge on DM) with the least 
score being 0. Corresponding scores for Section 
C (knowledge on HIV) and Section D (HIV/DM 
management) were 12 and 0 and 13 and 0 
respectively. For each section, respondents who 
had up to 50% of  the scores were classified as 
having good knowledge while those who scored 




A total of 219 respondents took part in the study. 
One hundred and seventy nine, 179 (81.7%) 
were females and 122 (55.7%) aged 40 years and  
above while the rest 44.3% were below 40 years. 
Almost half (48.4%) of the Health Care Providers 
(HCP) were Nurses and/or midwives, 29.7% 
were Community Health Extension Workers 
(CHEWs), 
13.7% were Doctors, 4.6% were Pharmacists and 
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3.7% were Laboratory Scientists. Almost two 
thirds (63.5%) of the respondents (HCP) 
practiced in urban areas and the remaining 
36.5% in rural areas.  In terms of Health Care 
Facility Practice level, 51.6% of the HCP 
practiced at the Primary level of care and 30.6% 
at the secondary level of care while 17.8% 
practiced at private hospitals. With regards to 
duration of practice, 43.8% of the HCP had 
practiced for 10 years or less, while 24.2% 
had practiced for between 11-20 years and 32% 
had practiced for upwards of 21 years (Table 1). 
 
Table 1: Socio-demographic characteristics of 
respondents 
 
VARIABLE Frequency Percentage    
n=219 
AGE GROUP 
Below Middle age 
(22-39 












Male 40 18.3 
Female 179 81.7 
LOCATION OF PRACTICE 
Urban 139 63.5 
Rural 80 36.5 
HEALTH CARE PROVIDER (HCP) PROFESSIONAL GROUP 







Pharmacists 10 4.6 
Laboratory 8 3.7 scientists 
CHEWs 65 29.7 others 
HEALTH CARE FACILITY PRACTICE LEVEL 
Primary 113 51.6 
Secondary 67 30.6 
Private 39 17.8 
DURATION OF PRACTICE 
≤ 10 years 96 43.8 
11-20 years 53 24.2 
21-35 years 70 32.0 
 
** Others- Medical Record Officers especially.  
 
Overall, two thirds (66.2%) of the HCP 
respondents had good knowledge on DM, while 
about three quarters (76.3%) had good 
knowledge on HIV. Only about a third (32.4%) of 
all respondents had good knowledge on effects of 
Management of HIV on DM (Fig1). 
 
Figure 1: Knowledge on Diabetes, HIV and effects 




Table 2 shows that when the socio-demographic 
characteristics and knowledge of respondents on 
DM were compared there was a statistically 
significant difference {P=0.002} among the HCPs’ 
various professional groups with all the eight 
Laboratory scientists having good knowledge 
followed by 86.7% of Doctors. Similar figures for 
others were- Pharmacists (70.0%), 
Nurses/Midwives-65.1%, while CHEWs and 
others had the lowest proportion of those who 
had good knowledge with 53.8%. There were 
also statistically significant differences for the 
variables sex, and duration of practice with 
males and those who have practised for 10 years 
or less having higher proportions of those who 
had good knowledge compared to females and 
those who had worked for more than 10 years 
respectively. 
 
There were no statistically significant differences 
for the variables age group, location and level of 
practice on the knowledge of DM.
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Table 2: Comparison of socio-demographic characteristics and knowledge of respondents on DM 
 
* Statistically significant at P< 0.05 ** - Likelihood ratio value used because at least one cell has an expected 
value of less than <5. 
 
Table 3 shows that when the socio-demographic characteristics and knowledge of respondents on HIV 
were compared there was a statistically significant difference {P=0.024} among the HCPs’ various 
professional groups with 90.0% of Doctors and Pharmacists having good knowledge Similar figures for 
others were- Nurses/Midwives-79.2%, Laboratory scientists- 75.0% while CHEWs and others had the 
lowest proportion of those who had good knowledge with 63.1%. There were no statistically significant 











Male 7(17.5) 33(82.5) 40(100.0) df= 1 
χ2 =5.805 p= 
0.016* Female 67(37.4) 112(62.6) 179(100.0) 
Age Group 
Below Middle age 26(26.8) 71(73.2) 97(100.0) df= 1 
χ2 = 3.798 
p=0.051 Middle Age & above 48(39.3) 74(60.7) 122(100.0) 
HCP Professional 
Group 
Doctors 4(13.3) 26(86.7) 30(100.0) 
df= 4 
χ2 = 17.523** 
p=0.002* 
Nurses/ Midwives 37(34.9) 69(65.1) 106(100.0) 
Pharmacists 3(30.0) 7(70.0) 10(100.0) 
Laboratory scientists 0(0.0) 8(100.0) 8(100.0) 
CHEWs, others 30(46.2) 35(53.8) 65(100.0) 
Level of 
Practice 
Primary 42(37.2) 71(62.8) 113(100.0) 
df= 2 
χ2 = 1.299 
p=0.522 
Secondary 21(31.3) 46(68.7) 67(100.0) 
Private 11(28.2) 28(71.8) 39(100.0) 
Duration of 
practice 
10 years& below 23(24.0) 73(76.0) 96(100.0) 
df= 2 
χ2 = 7.963 
p=0.019* 
11-20 years 20(37.7) 33(62.3) 53(100.0) 
21-35 years 31(44.3) 39(55.7) 70(100.0) 
Location of 
Practice 
Urban 43(30.9) 96(69.1) 139(100.0) df= 1 
χ2 = 1.386 
p=0.239 Rural 31(38.8) 49(61.3) 80(100.0) 
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Sex Male 5 (12.5) 35 (87.5) 40(100.0) 
df= 1 
χ2 = 3.417 p= 0.065 Female 47 (26.3) 132 (73.7) 179 (100.0) 
Age 
Group 
Below   Middle age 23(23.7) 74 (76.3) 97(100.0) 
df=1 
χ2 = 0.000 p=0.992 MiddleAge& 
above 
29 (23.8) 93 (76.2) 122 (100.0) 
HCP Professional 
Group 
Doctors 3 (10.0) 27 (90.0) 30 (100.0) 
df= 4 
χ2 = 11.193** 
p=0.024* 
Nurses/ Midwives 22 (20.8) 84 (79.2) 106 (100.0) 
Pharmacists 1 (10.0) 9 (90.0) 10 (100.0) 
Laboratory 
scientists 
2 (25.0) 6 (75.0) 8 (100.0) 
CHEWs, others 24 (36.9) 41(63.1) 65 (100.0) 
Level      of 
Practice 
Primary 31 (27.4) 82 (72.6) 113 (100.0) 
df= 2 
χ2 = 1.772 p=0.412 
Secondary 13 (19.4) 54 (80.6) 67 (100.0) 
Private 8 (20.5) 31 (79.5) 39 (100.0) 
Duration of 
practice 
10          years& 
below 
21 (21.9) 75 (78.1) 96 (100.0) 
df= 2 
χ2 = 0.824 p=0.662 
11-20 years 15 (28.3) 38 (71.7) 53 (100.0) 
21-35 years 16 (22.9) 54 (77.1) 70 (100.0) 
Location of 
Practice 
Urban 32 (23.0) 107 (77.0) 139 (100.0) 
df= 1 
χ2 = 0.110 p=0.740 Rural 20 (25.0) 60 (75.0) 80 (100.0) 
* Statistically significant at P< 0.05 ** - Likelihood ratio value used because at least one cell has an expected value of less than <5.
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Table 4 shows that when the socio-demographic 
characteristics and knowledge of respondents on 
effects of Management of HIV on DM were 
compared there was a statistically significant 
difference {P=0.001} among the HCPs’ various 
professional groups with 62.5% of Laboratory 
scientists having good knowledge followed by 
60.0% of Doctors. Similar figures for others 
were- Pharmacists (50.0%), Nurses/Midwives-
26.4%, while CHEWs and others had the lowest 
proportion of those who had good knowledge 
with 23.1%. There were also statistically 
significant differences for the variables sex, age 
group, location and duration of practice with 
males, those below 40 years, those located in 
urban areas and those who have practiced for 10 
years or less having higher proportions of those 
who had good knowledge compared to females, 
those 40 years and above (middle age),those 
located in rural areas and those who had worked 
for more than 10 years respectively. 
 
There was no statistically significant difference 
for the variable level of practice on the 
knowledge of effects of Management of HIV on 
DM
 
Table 4: Comparison of socio-demographic and other characteristics and knowledge of respondents on 
effects of Management of HIV on DM 
 








Sex Male 19(47.5) 21(52.5) 40(100.0) df= 1 
χ2 = 9.006* 
p= 0.003* 
Female 129(72.1) 50(27.9) 179(100.0) 
Age Group Below Middle age 55(56.7) 42(43.3) 97(100.0) df= 1 
χ2 =9.406 p=0.002* MiddleAge& above 93 (76.2) 29(23.8) 122(100.0) 
HCP Professional 
Group 
Doctors 12(40.0) 18(60.0) 30(100.0) df= 4 
χ2 = 18.484** 
p=0.001* 
Nurses/ Midwives 78(73.6) 28(26.4) 106(100.0) 
Pharmacists 5(50.0) 5(50.0) 10(100.0) 
Laboratory scientists 3 (37.5) 5(62.5) 8(100.0) 
CHEWs, others 50(76.9) 15(23.1) 65(100.0) 
Level                 of 
Practice 
Primary 83(73.5) 30(26.5) 113(100.0) df= 2 
χ2 =3.675 p=0.159 Secondary 41(61.2) 26(38.8) 67(100.0) 
Private 24(61.5) 15(38.5) 39(100.0) 
Duration         of 
practice 
10 years& below 57(59.4) 39(40.6) 96(100.0) df= 2 
χ2 = 7.936 p=0.019* 11-20 years 35(66.0) 18(34.0) 53(100.0) 
21-35 years 56(80.0) 14(20.0) 70(100.0) 
Location          of 
Practice 
Urban 83(59.7) 56(40.3) 139(100.0) df= 1 
χ2 = 10.751 
p=0.001* 
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There is a dearth of works that considered the 
knowledge of the effect of HIV disease treatment 
on the incidence of diabetes mellitus either 
within a particular group of health workers e.g.  
Doctors, Nurses or among the various categories 
of health care providers. 
 
In this study, about two thirds of respondents 
had good knowledge on DM and over three 
quarters had good knowledge on HIV disease, 
meaning that a majority of them fared well 
separately on DM and HIV disease. However, less 
than a third of them scored good knowledge on 
the effect of HIV disease treatment on DM. This 
showed that a good majority of them didn’t 
appreciate the role HIV treatment could play in 
secondarily making patients with unguided 
chemotherapy develop DM. Studies have been 
carried out that showed that antiretroviral 
therapy especially prolonged use of Protease 
Inhibitors in HIV disease patients could increase 
their susceptibility to type 2 DM (Christine A 
Hughes et al 2005 and Andeel A. Butt et al 2009). 
In one such study, it was made known that 
prolonged use of ARV drugs generally could 
increase the incidence of DM in these patients 
(Shrestha M et al 
2015). The implication is that, patients should be 
selected in the choices of HAART regimen they 
would be treated with.  In the same vein, pre-
existing DM should be ruled out so as to discern 
in 
the event of occurrence of DM, whether it 
predated the commencement of HAART or not. 
Management algorithms for HIV under certain 
medical conditions could be helpful so as to know 
the parameters to be weary of when treating 
HIV/AIDS patients. 
 
Concerning knowledge of respondents on DM, all 
the health workers were found to have good 
knowledge with all the Laboratory Scientists 
taking a significant lead (P<0,05) closely 
followed by the Doctors with over 85% of them 
also having a good knowledge. This may not be  
 
 
surprising if one considers the fact that 
Laboratory Scientists play crucial    role     in     
making    the     diagnosis    of 
uncomplicated DM many times. The CHEWs and 
others out of whom 53.8% had good knowledge 
occupied the lowest level. Our work is in contrast 
with other closely related studies in which health 
care workers including Physicians were found to 
possess inadequate knowledge. In one such 
study over three quarters of pharmacy personnel 
were found to have a poor knowledge on 
diabetes mellitus management despite the fact 
that the majority of patients consult with them 
more than the physicians (Jinqi M, Nansseu  JR,  
Noubiap  JJ 2015). Also, from a recent study in 
Cameroon, Physicians’ knowledge towards 
diabetes evaluation and management was found 
not to be optimal (Ruud KW, Srinivas SC, 
Toverud EL 2014). This trend poses a great 
danger considering the silent nature of DM and 
also hypertension at their initial stages. 
 
Though no study had evaluated DM knowledge of 
health care workers as regards sex of personnel 
and duration of practice, we found in our study 
that male personnel and those who had practised 
for 10 or more years significantly occupied 
greater percentages among those having good 
knowledge. The additional pressure from home 
management could affect the women while many 
times duration of practice could positively affect 
knowledge, though with negligence and failure to 
update the reverse may be the case. 
 
Concerning the knowledge of respondents on 
HIV, all the health workers in this study again 
were found to have good knowledge with the 
Doctors taking the lead with 90% of them 
exhibiting good knowledge and CHEWs and 
others just like for DM scored the least though 
about 63 % of them also had good knowledge. In 
a study done in South Africa evaluating the 
knowledge of health care providers on HIV and 
its treatment, Nurses and Auxiliary staff were 
found to have some basic knowledge about  
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symptoms and mode of transmission of HIV, but 
great uncertainty was seen regarding treatment 
with ARV drugs. As much as 39% of the Nurses 
claimed that nutritious food could also treat HIV 
disease (Ruud KW, Srinivas SC, Toverud EL 
2014). No doubt, good diet is necessary so as to 
respond to treatment and to supply the minerals 
that help immunity to build, but treating an 
ailment that has a causation factor entails either 
the removal, incapacitation or slowing the 




Respondents in this survey demonstrated good 
level of knowledge of MD and HIV, but poor 
awareness of HAART induced metabolic 
disorder. For health care providers to offer the 
best treatment options to their patients, they 
must possess good knowledge of the diseases 
and must be aware of the short and long term 
effects of the treatment options including 
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